Marco Donia

University of Copenhagen — Denmark

Medicine · Health Sciences

56h-index13.9kcitations501works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(268), CAR-T cell therapy research(209), Immunotherapy and Immune Responses(190), Immune Cell Function and Interaction(70), Melanoma and MAPK Pathways(44)

Publications498 total

Dynamics of checkpoint receptors in γδ T cell subsets are associated with clinical response during anti-PD-1 immunotherapies
EMBO Molecular Medicine·2025Open Access
Supplementary Material 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
2025Open Access
Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
2025Open Access
Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
2025Open Access
Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
2025Open Access
514 Biomarker insights and long-term outcomes of TILT-123 oncolytic adenovirus combined with tumor-infiltrating lymphocytes in refractory metastatic melanoma: results from the TUNINTIL phase 1 trial
Regular and Young Investigator Award Abstracts·2025Open Access
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
Journal for ImmunoTherapy of Cancer·2025· 2 citedOpen Access
Assessment of Diffuse and Focal Myocardial Fibrosis in Hypertrophic Cardiomyopathy Using Native T1 Mapping, Extracellular Volume, and Late Gadolinium Enhancement
Benha Medical Journal·2025
Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study
JCO Oncology Practice·2025
The proteomics and phosphoproteomics landscape of melanoma under T cell attack
2025· 1 citedOpen Access
Dabrafenib plus trametinib vs encorafenib plus binimetinib in <i>BRAF</i> -mutant metastatic melanoma: a real-world propensity score–matched survival analysis
JNCI Journal of the National Cancer Institute·2025
1654P Impact of tumor infiltrating lymphocyte therapy on the outcome of BRAF and MEK inhibitor treatment for advanced melanoma
Annals of Oncology·2025
1528P Estimating the rate and global burden of acquired resistance to checkpoint inhibitors in solid tumors
Annals of Oncology·2025
1608P Fertility outcomes in young female patients treated with adjuvant anti-PD-1 therapy for resectable melanoma
Annals of Oncology·2025
1547P Clinical outcomes of patients with acquired resistance to checkpoint inhibitors in melanoma, renal cell carcinoma and non-small cell lung cancer
Annals of Oncology·2025Open Access
127O Response to TIL therapy depends on a tumor-intrinsic IL-2 signaling axis that drives expansion of CD25+ tumor-reactive T cells
ESMO Open·2025Open Access
The Challenge of Treating Anti-PD-1-Resistant Advanced Melanoma
American Journal of Clinical Dermatology·2025
The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma
European Journal of Cancer·2025· 1 cited
Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial
Annals of Oncology·2025· 2 citedOpen Access
Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial
British journal of surgery·2025· 2 citedOpen Access
page 1 of 25Next →

Frequent Co-authors

Inge Marie Svane(37), Rikke Andersen(12), Özcan Met(11), Per thor Straten(11), Ferdinando Nicoletti(9), Mads Hald Andersen(8), Marie Christine Wulff Westergaard(8), Troels Holz Borch(7), Sine Reker Hadrup(7), Göran Jönsson(6), Paolo Fagone(6), James A. McCubrey(6), Eva Ellebæk(6), Magnus Pedersen(6), Linda S. Steelman(5), William H. Chappell(5), Stephen L. Abrams(5), Franca Stivala(5), Massimo Libra(5), Jörg Bäsecke(5)